Skip to main content

Table 1 Tukey-honest significant differences post-hoc test for Proseek data [Stage specific (A-D)] and healthy unaffected control (group E)

From: A novel multiplexed immunoassay identifies CEA, IL-8 and prolactin as prospective markers for Dukes’ stages A-D colorectal cancers

Candidate Biomarker

Comparison

Up/Down of expression

Adjusted p-value

Previous studies referring CRC associations

CEA

D/A

0

[15-21]

 

D/E

1.70E-12

 

D/B

4.13E-12

 

D/C

0.0001

 

C/A

0.0076

 

C/E

0.0304

IL-8

D/E

1.23E-06

[44,47]

 

D/A

2.96E-05

 

Prolactin

C/D

1.24E-05

[49-51]

 

C/E

2.89E-05

 

Amphiregulin

D/A

8.95E-07

[54]

 

D/C

1.46E-06

 

PDGF-BB

D/A

3.02E-05

[22,55]

IL-6

B/A

0.0024

[43,56]

 

B/E

0.0124

 

CXCL11

D/C

0.0155

[57]

 

D/A

0.0387

 

CXCL5

D/A

0.0424

[58-61]